Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 18638 | 476 | 41.6 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BAG 1 | Author keyword | 102 | 69% | 18% | 86 |
| 2 | BAG3 | Author keyword | 53 | 69% | 10% | 46 |
| 3 | DR H BLISS MURPHY CANC | Address | 13 | 80% | 2% | 8 |
| 4 | BAG 3 | Author keyword | 6 | 100% | 1% | 4 |
| 5 | BIOUNIVERSA SRL | Address | 5 | 55% | 1% | 6 |
| 6 | BAG1 | Author keyword | 4 | 38% | 2% | 9 |
| 7 | BCL 2 ASSOCIATED ATHANOGENE | Author keyword | 4 | 75% | 1% | 3 |
| 8 | CANC SCI CANC UK ONCOL UNIT | Address | 4 | 75% | 1% | 3 |
| 9 | BAG 4 | Author keyword | 3 | 100% | 1% | 3 |
| 10 | BCL 2 ASSOCIATED ATHANOGENE 1 | Author keyword | 3 | 100% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BAG 1 | 102 | 69% | 18% | 86 | Search BAG+1 | Search BAG+1 |
| 2 | BAG3 | 53 | 69% | 10% | 46 | Search BAG3 | Search BAG3 |
| 3 | BAG 3 | 6 | 100% | 1% | 4 | Search BAG+3 | Search BAG+3 |
| 4 | BAG1 | 4 | 38% | 2% | 9 | Search BAG1 | Search BAG1 |
| 5 | BCL 2 ASSOCIATED ATHANOGENE | 4 | 75% | 1% | 3 | Search BCL+2+ASSOCIATED+ATHANOGENE | Search BCL+2+ASSOCIATED+ATHANOGENE |
| 6 | BAG 4 | 3 | 100% | 1% | 3 | Search BAG+4 | Search BAG+4 |
| 7 | BCL 2 ASSOCIATED ATHANOGENE 1 | 3 | 100% | 1% | 3 | Search BCL+2+ASSOCIATED+ATHANOGENE+1 | Search BCL+2+ASSOCIATED+ATHANOGENE+1 |
| 8 | HSP70 HSC70 | 3 | 100% | 1% | 3 | Search HSP70+HSC70 | Search HSP70+HSC70 |
| 9 | RAP46 | 3 | 100% | 1% | 3 | Search RAP46 | Search RAP46 |
| 10 | SILENCER OF DEATH DOMAINS | 3 | 100% | 1% | 3 | Search SILENCER+OF+DEATH+DOMAINS | Search SILENCER+OF+DEATH+DOMAINS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | APOPTOTIC PROTEIN BAG 1 | 99 | 87% | 10% | 48 |
| 2 | HSP70 HSC70 | 56 | 85% | 6% | 29 |
| 3 | BCL 2 BINDING PROTEIN | 48 | 73% | 8% | 37 |
| 4 | DEATH ACTIVITY | 34 | 93% | 3% | 13 |
| 5 | ALTERNATIVE TRANSLATION INITIATION | 31 | 49% | 9% | 45 |
| 6 | PROTEIN BAG 1 | 21 | 90% | 2% | 9 |
| 7 | CELL DEATH ACTIVITY | 12 | 86% | 1% | 6 |
| 8 | ENHANCES ANDROGEN RECEPTOR | 12 | 86% | 1% | 6 |
| 9 | HSC70 CHAPERONE | 11 | 56% | 3% | 14 |
| 10 | GENE BAG 1 | 11 | 100% | 1% | 6 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| BAG3: a multifaceted protein that regulates major cell pathways | 2011 | 56 | 62 | 65% |
| BAG3: a new therapeutic target of human cancers? | 2012 | 13 | 37 | 81% |
| What's in the 'BAG'? - a functional domain analysis of the BAG-family proteins | 2002 | 113 | 52 | 73% |
| A CHIPotle in physiology and disease | 2015 | 1 | 175 | 23% |
| The BAG proteins: a ubiquitous family of chaperone regulators | 2008 | 70 | 88 | 51% |
| CHIP: a link between the chaperone and proteasome systems | 2003 | 222 | 22 | 36% |
| BAGo-1 - A nucleotide exchange factor of Hsc70 with multiple cellular functions | 2003 | 81 | 58 | 72% |
| BAG-1: a multifunctional regulator of cell growth and survival | 2003 | 70 | 99 | 70% |
| BAG-I expression and function in human cancer | 2002 | 29 | 25 | 96% |
| Role of BAG3 protein in leukemia cell survival and response to therapy | 2012 | 5 | 76 | 54% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DR H BLISS MURPHY CANC | 13 | 80% | 1.7% | 8 |
| 2 | BIOUNIVERSA SRL | 5 | 55% | 1.3% | 6 |
| 3 | CANC SCI CANC UK ONCOL UNIT | 4 | 75% | 0.6% | 3 |
| 4 | PHARMACEUT BIOMED SCI FARMABIOMED | 3 | 50% | 0.8% | 4 |
| 5 | PHARMACEUT SCI DIFARMA | 2 | 40% | 0.8% | 4 |
| 6 | BIOMED ARTURO LEONE | 1 | 50% | 0.4% | 2 |
| 7 | CARDIOL CAROLINA CARDIOVASC BIOL | 1 | 50% | 0.4% | 2 |
| 8 | PROGRAM MOL CARDIOL | 1 | 20% | 1.1% | 5 |
| 9 | CANC UK COLORECTAL TUMOUR BIOL GRP | 1 | 20% | 0.8% | 4 |
| 10 | CANC UK ONCOL UNIT | 1 | 17% | 0.8% | 4 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000173306 | DNAJ//GRPE//DNAK |
| 2 | 0.0000163606 | SCYTHE//GET PATHWAY//SGTA |
| 3 | 0.0000083748 | HSP90//GELDANAMYCIN//HSP90 INHIBITORS |
| 4 | 0.0000072664 | TID1//HRFI//DNAJB1 |
| 5 | 0.0000066223 | BCL 2//BCL 2 PROTEIN//BCL X |
| 6 | 0.0000063354 | DSK2//UBIQUILIN 1//LUBAC |
| 7 | 0.0000062967 | HIPK2//CACYBP SIP//CACYBP |
| 8 | 0.0000058434 | HSP27//HEAT SHOCK PROTEIN 27//CHAPERONOTHERAPY |
| 9 | 0.0000053353 | HSF1//HEAT SHOCK FACTOR//HEAT SHOCK FACTOR 1 |
| 10 | 0.0000053341 | QILIQIANGXIN//DESMIN RELATED CARDIOMYOPATHY//PROT QUAL CONTROL DE AT |